Sign In
Free Newsletter
Health Care 2025: DACEY, DR. MICHAEL J.
Dacey became Riverside Health‘s CEO in 2023, in addition to serving as president. Riverside has more than 9,500 employees and operates seven hospitals — including Riverside Mental Health & Recovery Center, Virginia’s first stand-alone psychiatric emergency department — in Newport News, Williamsburg, Hampton, Yorktown, Gloucester and Onancock, as well as over 110 medical offices[...]
AstraZeneca to locate pharma plant in Albemarle
AstraZeneca and Eli Lilly & Co. are planning to locate major manufacturing facilities in Albemarle and Goochland counties.
FDA’s new expert panels are rife with financial conflicts and fringe views
FDA Commissioner Marty Makary is using informal expert panels on antidepressants, menopause drugs and talc, raising conflict-of-interest concerns.
AstraZeneca plans multibillion-dollar pharma factory in Virginia
AstraZeneca plans to construct a multi-billion dollar manufacturing center focused on chronic diseases in Virginia within the next five years.
Pharma hub workforce training wins $3.9 million grant
The talent pipeline for the Richmond-Petersburg region’s growing advanced pharmaceutical manufacturing and biotech industries is getting a boost from a $3.9 million federal grant. Announced in mid-January, the U.S. Economic Development Administration’s Good Jobs Challenge grant was awarded to the Community College Workforce Alliance in Disputanta, a shared division of Brightpoint and [...]
Pharma company to invest $54.2M in Richmond R&D facility
Pharmaceutical company Haleon will invest $54.2 million to upgrade its research and development facility in Richmond and launch an internship program in partnership with state government and Virginia Commonwealth University, Gov. Glenn Youngkin announced Monday. The physical upgrades at the facility, located at 1211 Sherwood Ave., will allow United Kingdom-based Haleon to accommodate new technolog[...]
Va. to receive $107.4M in updated opioids settlement
Virginia stands to receive up to $107.4 million in a multistate settlement proposed by OxyContin producer Purdue Pharma and its owners, the Sackler family, Virginia Attorney General Jason Miyares announced Thursday. The defendants in the federal case have offered to pay $7.4 billion to 14 states to settle claims that under the leadership of the […]
Food City to pay $8.4M to settle opioids-related allegations
Abingdon-based K-VA-T Food Stores, operator of the Food City supermarket chain, has agreed to pay more than $8.4 million to the federal government to settle allegations under the False Claims Act (FCA) related to dispensing opioids and other controlled substances. The U.S. Department of Justice announced the agreement with K-VA-T Food Stores Monday, In a statement, […]
Pharma company invests $1.5M on Prince William expansion
Pharmaceutical manufacturer Granules Consumer Health, a subsidiary of Granules India, will invest $1.5 million into expanding its operations in Prince William County, Gov. Glenn Youngkin announced Monday. The company plans to install new manufacturing lines at its existing Manassas facility, with an aim of creating nearly 100 new jobs. “Granules’ decision to expand their operations [&h[...]
Afton Scientific announces $200M Albemarle expansion
Afton Scientific, a manufacturer of sterile injectable pharmaceuticals, plans to invest over $200 million to expand its manufacturing facility in Albemarle County, Gov. Glenn Youngkin announced Wednesday. The expansion is projected to create more than 200 jobs. Founded by Thomas Thorpe in Charlottesville in 1991, Afton Scientific is a contract development and manufacturing organization (CMDO), [&h[...]
Reports: Novo Nordisk in talks to buy Petersburg Ampac plant
Two South Korean media outlets have reported that the South Korean owner of Ampac Fine Chemicals may sell its manufacturing plant in Petersburg to Novo Nordisk, the Danish global pharmaceutical company. Sources told The Korea Economic Daily that the Seoul-based manufacturing conglomerate SK Group, which purchased Ampac in 2018 for a reported $576 million, is […]
Briggman leaving post as CEO of Activation Capital
Chandra Briggman is leaving her position as president and CEO of Activation Capital, the Richmond tech incubator announced Monday. Her last day is Friday. Briggman joined Activation Capital, an accelerator arm of the Virginia Biotechnology Research Partnership Authority, in May 2020; the organization includes a biotech park, startup development and cluster accelerator for pharmaceutical research [[...]
